Norwegian salmon farmer's investment arm injects cash into biotech company

The company's technology is based on hyperthermophilic bacteria to degrade biomass for biogas and protein production. The main markets are fish farmers and biogas producers.

Tore Hopen, CEO of Farvatn Private Equity, believes Hyperthermics' unique approach to converting waste into climate‐neutral energy and proteins can help fish farmers.
Tore Hopen, CEO of Farvatn Private Equity, believes Hyperthermics' unique approach to converting waste into climate‐neutral energy and proteins can help fish farmers.Photo: Farvatn Private Equity
Published 16 June 2022, 09:30Updated 16 June 2022, 13:14
NorwayMasoval FiskeoppdrettPrivate equityInvestmentsbiotech